Sildenafil Oral Medication for Erectile Dysfunction - A Review
Abstract
A Common Drug That Is A Member Of The Phosphodiesterase-5 Inhibitor (Pde5-I) Class Is Sildenafil. It Is Mainly
Prescribed To Treat Pulmonary Arterial Hypertension (Pah) And Erectile Dysfunction (Ed). This Study Offers A Thorough
Analysis Of Sildenafil, Emphasising Its Pharmacological Underpinnings, Therapeutic Uses, And Modes Of Action.
Furthermore, The Paper Addresses The Possible Negative Consequences And Contraindications Related To Its Application. To
Effectively Manage Linked Disorders And Optimise Patient Care, Healthcare Providers Must Have A Complete Awareness Of
These Aspects. In Order To Get The Best Possible Treatment Results With Sildenafil, The Study Emphasises The Significance
Of Proper Patient Selection And Monitoring. By Raising The Amount Of Cyclic Guanosine Monophosphate In The Corpora
Cavernosa, The Particular Phosphodiesterase Type V Inhibitor Sildenafil Improves Erection Upon Sexual Stimulation. This Has
Completely Changed How Erectile Dysfunction Is Treated. Even While The Medication Seems Highly Promising And Has Few
Side Effects, There Are Still A Lot Of Concerns About Its Safety, Effectiveness, And Potential For Abuse And Overuse
Read the paper
Related studies
- 2024 update in heart failure
- Vascular involvement in idiopathic pulmonary fibrosis
- A novel technique- subendometrial autologous platelet rich plasma injection in patients with unresponsive thin endometrium undergoing frozen-thawed embryo transfer: a prospective cohort study
- Does metformin prolong pregnancy in preterm pre-eclampsia? A study protocol for a South African, hospital-based double-blind, randomised, placebo-controlled trial
- Combined Pulmonary Fibrosis and Emphysema (CPFE): A "New" Smoking-Related Interstitial Lung Disease (ILD)
- Impact of an acute 1-month cannabidiol treatment on pain and inflammation after a long bone fracture: a triple-blind randomised, placebo-controlled, clinical trial protocol
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.